2007 News

• 11.02.2007
  Press Release

  Santen Announces Financial Result FY 2007 Half Year

• 11.02.2007
  Press Release

  Agreement Concerning Glaucoma and Ocular HypertensionTreatment RESCULA® Eye Drops

• 10.02.2007
  Press Release IR News

  Santen to Redesign Sante de U Plus E Alfa Package

• 07.31.2007
  Press Release IR News

  Santen Announces Financial Result for FY2007 First Quarter

• 07.03.2007
  Press Release IR News

  Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)

• 06.26.2007
  IR News

  Resolution Notice of The 95th Annual General Meeting of Shareholders

• 06.26.2007
  Press Release IR News

  Notice on the Allotment of Stock Options (Stock Acquisition Rights)

• 06.01.2007
  Press Release IR News

  Convocation Notice of the 95th Annual General Meeting of Shareholders

• 05.22.2007
  Press Release IR News

  Extension of Nara Research and Development Center

• 05.10.2007
  Press Release IR News

  Santen to Issue Stock Acquisition Rights to the Directors for the Purpose of Granting Stock Options

• 05.08.2007
  Press Release IR News

  Santen Announces Financial Results for the Year ended March 31,2007

• 05.08.2007
  Press Release IR News

  Introduction of Takeover Defense Measures

• 04.09.2007
  Press Release IR News

  Santen to Launch Sante Uruoi Contact a

• 04.03.2007
  Press Release IR News

  Santen Oy Submits Marketing Approval for Glaucoma and Ocular Hypertension Drug Candidate DE-085

• 04.02.2007
  Press Release IR News

  Santen Opens its Shenyang Representative Office

• 03.29.2007
  Press Release IR News

  Noto Plant Product Line to Resume

• 03.26.2007
  Press Release IR News

  Impact of Noto Peninsula Earthqauke, Ishikawa Prefecture

• 02.27.2007
  Press Release IR News

  Santen Announces Proposed Dividends Change

• 02.09.2007
  Press Release IR News

  Changes in Significant Shareholder

• 01.31.2007
  Press Release IR News

  Santen Announces Financial Result for the Third Quarter ended December31, 2006

News Archive